Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1
Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Regorafenib in Relapsed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
- Status
- TERMINATED
- Phase
- PHASE2
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
- Status
- TERMINATED
- Phase
- PHASE1
Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1
Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide Chronotherapy for High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
- Status
- UNKNOWN
- Phase
- PHASE2
Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
- Status
- TERMINATED
- Phase
- N/A
Determination of Immune Phenotype in Glioblastoma Patients
- Status
- COMPLETED
- Phase
- N/A
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
- Status
- TERMINATED
- Phase
- PHASE1
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
- Status
- COMPLETED
- Phase
- PHASE2